A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations
Latest Information Update: 15 May 2025
At a glance
- Drugs ALG 055009 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Pharmacokinetics
- Sponsors Aligos Therapeutics
Most Recent Events
- 15 May 2025 New trial record